[Current status of VEGF-targeted therapy and multiple-targeted receptor tyrosine kinase inhibitors targeting VEGF and FGF-receptors].
Funahashi
Yasuhiro
Y
y-funahashi@hhc.eisai.co.jp
D000970:Antineoplastic Agents / Q000494:pharmacology*; D016503:Drug Delivery Systems; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D017468:Receptors, Fibroblast Growth Factor / Q000037:antagonists & inhibitors*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D017468:Receptors, Fibroblast Growth Factor; D040262:Receptors, Vascular Endothelial Growth Factor